LiuYZhuJLaiJM, et al. Reports of three cases with the initial presentation of mesenteric vasculitis in children with system lupus erythematous.Clin Rheumatol2018; 37: 277–283.
2.
MokCC.Calcineurin inhibitors in systemic lupus erythematosus.Best Pract Res Clin Rheumatol2017; 31: 429–438.
3.
Al-MogairenSM.Lupus protein-losing enteropathy (LUPLE): a systematic review.Rheumatol Int2011; 31: 995–1001.
4.
ChangYSLaiCCChenWSWangSHChouCT andTsaiCY.Protein-losing enteropathy and premature ovarian failure in a young woman with systemic lupus erythematosus.Lupus2012; 21: 1237–1239.
5.
HillPADwyerKM andPowerDA.Chronic intestinal pseudo-obstruction in systemic lupus erythematosus due to intestinal smooth muscle myopathy.Lupus2000; 9: 458–463.
6.
ThorneKAlrubaiyLAkbariASamuelDGSianMR andStephenER.Colectomy rates in patients with ulcerative colitis following treatment with infliximab or ciclosporin: a systematic literature review.Eur J Gastroenterol Hepatol2016; 28: 369–382.
7.
McCuneWJGolbusJZeldesWBohlkePDunneR andFoxDA.Clinical and immunologic effects of monthly administration of intravenous cyclophosphamide in severe systemic lupus erythematosus. N Engl J Med1988; 318: 1423–1431.
8.
DalmarcoEMFrödeTS andMedeirosYS.Additional evidence of acute anti-inflammatory effects of cyclosporin A in a murine model of pleurisy. Transpl Immunol2004; 12: 151–157.
